AAAAAA

   
Results: 1-21 |
Results: 21
Determinants of mean arterial pressure and pulse pressure in chronic haemodialysis patients
Authors: Abdelfatah, AB Motte, G Ducloux, D Chalopin, JM
Citation: Ab. Abdelfatah et al., Determinants of mean arterial pressure and pulse pressure in chronic haemodialysis patients, J HUM HYPER, 15(11), 2001, pp. 775-779
Renal involvement after lung transplantation for sarcoidosis
Authors: Motte, G Ducloux, D Dubiez, A Justrabo, E Chalopin, JM
Citation: G. Motte et al., Renal involvement after lung transplantation for sarcoidosis, CLIN NEPHR, 56(5), 2001, pp. 411-412
Use of pentoxifylline in membranous nephropathy
Authors: Ducloux, D Bresson-Vautrin, C Chalopin, JM
Citation: D. Ducloux et al., Use of pentoxifylline in membranous nephropathy, LANCET, 357(9269), 2001, pp. 1672-1673
Serum total homocysteine and cardiovascular disease occurrence in chronic,stable renal transplant recipients: A prospective study
Authors: Ducloux, D Motte, G Challier, B Gibey, R Chalopin, JM
Citation: D. Ducloux et al., Serum total homocysteine and cardiovascular disease occurrence in chronic,stable renal transplant recipients: A prospective study, J AM S NEPH, 11(1), 2000, pp. 134-137
Flow-PRA (R) evaluation for antibody screening in patients awaiting kidneytransplantation
Authors: Rebibou, JM Chabod, J Bittencourt, MC Thevenin, C Chalopin, JM Herve, P Tiberghien, P
Citation: Jm. Rebibou et al., Flow-PRA (R) evaluation for antibody screening in patients awaiting kidneytransplantation, TRANSPL IMM, 8(2), 2000, pp. 125-128
Cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion
Authors: Thervet, E Morelon, E Ducloux, D Bererhi, L Noel, LH Bedrossian, JJ Puget, S Chalopin, JM Mihatsch, M Legendre, C Kreis, H
Citation: E. Thervet et al., Cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion, CLIN TRANSP, 14(6), 2000, pp. 561-566
Flow-PRA evaluation for antibody screening in patients awaiting kidney transplantation
Authors: Rebibou, JM Chabod, J Bittencourt, MC Thevenin, C Chalopin, JM Herve, P Tiberghien, P
Citation: Jm. Rebibou et al., Flow-PRA evaluation for antibody screening in patients awaiting kidney transplantation, TRANSPLAN P, 32(8), 2000, pp. 2745-2746
The interest of flow cytometry for the detection of pregnancy-induced alloimmunization
Authors: Rebibou, JM Chabod, J Dupont, I Chalopin, JM Tiberghien, P
Citation: Jm. Rebibou et al., The interest of flow cytometry for the detection of pregnancy-induced alloimmunization, TRANSPLAN P, 32(8), 2000, pp. 2747-2747
Anti-class II antibodies in kidney transplant patients
Authors: Rebibou, JM Bittencourt, MC Ducloux, D Chabod, J Thevenin, C Chalopin, JM Herve, P Tiberghien, P
Citation: Jm. Rebibou et al., Anti-class II antibodies in kidney transplant patients, TRANSPLAN P, 32(8), 2000, pp. 2748-2749
A pilot study of cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion
Authors: Thervet, E Morelon, E Ducloux, D Bererhi, L Noel, LH Janin, A Bedrossian, J Puget, S Chalopin, JM Mihatsch, M Legendre, C Kreis, H
Citation: E. Thervet et al., A pilot study of cyclosporine withdrawal in stable renal transplant recipients after azathioprine-mycophenolate mofetil conversion, TRANSPLAN P, 32(8), 2000, pp. 2778-2778
Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids
Authors: Lebranchu, Y Aubert, P Bayle, F Bedrossian, J Berthoux, F Bourbigot, B Buchler, M Chalopin, JM Deteix, P Glotz, D De Ligny, BH Kessler, M Lang, P Lefrancois, N Le Pogamp, P Moulin, B Mourad, G Olmer, M Sraer, JD Touchard, G Toupance, O Wolf, P Puget, S
Citation: Y. Lebranchu et al., Could steroids be withdrawn in renal transplant patients sequentially treated with ATG, cyclosporine, and cellcept? One-year results of a double-blind, randomized, multicenter study comparing normal dose versus low-dose and withdrawal of steroids, TRANSPLAN P, 32(2), 2000, pp. 396-397
Systemic hypertension and renal function in long-term liver transplant recipients on cyclosporine
Authors: Semhoun-Ducloux, S Ducloux, D Bresson-Hadni, S Becker, MC Vanlemmens, C Mantion, G Chalopin, JM Miguet, JP
Citation: S. Semhoun-ducloux et al., Systemic hypertension and renal function in long-term liver transplant recipients on cyclosporine, TRANSPLAN P, 32(2), 2000, pp. 449-452
T-cell immune defect and B-cell activation in renal transplant recipients with monoclonal gammopathies
Authors: Ducloux, D Carron, PL Racadot, E Rebibou, JM Bresson-Vautrin, C Hillier, YS Chalopin, JM
Citation: D. Ducloux et al., T-cell immune defect and B-cell activation in renal transplant recipients with monoclonal gammopathies, TRANSPLAN I, 12(4), 1999, pp. 250-253
Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus
Authors: Ducloux, D Motte, G Vautrin, P Bresson-Vautrin, C Rebibou, JM Chalopin, JM
Citation: D. Ducloux et al., Polycystic kidney disease as a risk factor for post-transplant diabetes mellitus, NEPH DIAL T, 14(5), 1999, pp. 1244-1246
Inferior vena cava thrombosis in a patient with chlorpromazin-induced anticardiolipin antibodies
Authors: Ducloux, D Florea, A Fournier, V Rebibou, JM Chalopin, JM
Citation: D. Ducloux et al., Inferior vena cava thrombosis in a patient with chlorpromazin-induced anticardiolipin antibodies, NEPH DIAL T, 14(5), 1999, pp. 1335-1336
Dialysis adequacy and homocyst(e)ine concentrations in peritoneal dialysispatients
Authors: Ducloux, D Heuze-Lecornu, L Gibey, R Bresson-Vautrin, C Vautrin, P Chalopin, JM
Citation: D. Ducloux et al., Dialysis adequacy and homocyst(e)ine concentrations in peritoneal dialysispatients, NEPH DIAL T, 14(3), 1999, pp. 728-731
Atheroembolic disease associated with the use of low-molecular-weight heparin during haemodialysis
Authors: Carron, PL Florea, A Ducloux, D Jamali, M Chalopin, JM
Citation: Pl. Carron et al., Atheroembolic disease associated with the use of low-molecular-weight heparin during haemodialysis, NEPH DIAL T, 14(2), 1999, pp. 520-521
Renal papillary necrosis in a marathon runner
Authors: Ducloux, D Lemouel, A Chalopin, JM
Citation: D. Ducloux et al., Renal papillary necrosis in a marathon runner, NEPH DIAL T, 14(1), 1999, pp. 247-248
Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients
Authors: Ducloux, D Pellet, E Fournier, V Rebibou, JM Bresson-Vautrin, C Racadot, E Fellmann, D Chalopin, JM
Citation: D. Ducloux et al., Prevalence and clinical significance of antiphospholipid antibodies in renal transplant recipients, TRANSPLANT, 67(1), 1999, pp. 90-93
Ocular venous occlusion and hyperhomocysteinemia
Authors: Ducloux, D Bresson-Vautrin, C Chalopin, JM
Citation: D. Ducloux et al., Ocular venous occlusion and hyperhomocysteinemia, ANN INT MED, 131(7), 1999, pp. 548-549
Mycophenolate mofetil in cyclosporin-associated thrombotic microangiopathy
Authors: Lecornu-Heuze, L Ducloux, D Rebibou, JM Martin, L Billerey, C Chalopin, JM
Citation: L. Lecornu-heuze et al., Mycophenolate mofetil in cyclosporin-associated thrombotic microangiopathy, NEPH DIAL T, 13(12), 1998, pp. 3212-3213
Risultati: 1-21 |